Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix

Go back to Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix
AVOCENT (NASDAQ: AVCT) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $25.13 
Open $1.29    52 Week Low $9.89 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $-1.04 
Volume 11,813